Evidence map›Paper›PMID 38623720›Full record

ReviewMolecular omics2024

Implementation of multiomic mass spectrometry approaches for the evaluation of human health following environmental exposure.

Christina R Ferreira, Paulo Clairmont F de Lima Gomes, Kiley Marie Robison, Bruce R Cooper, Jonathan H Shannahan

Abstract readReview
In one paragraph

Review in Molecular omics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christina R FerreiraPurdue Metabolite Profiling Facility, Purdue University, West Lafayette, IN 47907, USA. cferrei@purdue.edu.ORCID http://orcid.org/0000-0003-3988-6454
Paulo Clairmont F de Lima GomesSao Paulo State University Julio de Mesquita Filho, Institute of Chemistry, Araraquara, Sao Paulo, Brazil.ORCID http://orcid.org/0000-0002-4837-6352
Kiley Marie RobisonSchool of Health Sciences, College of Health and Human Sciences, Purdue University, West Lafayette, IN 47907, USA.
Bruce R CooperPurdue Metabolite Profiling Facility, Purdue University, West Lafayette, IN 47907, USA. cferrei@purdue.edu.
Jonathan H ShannahanSchool of Health Sciences, College of Health and Human Sciences, Purdue University, West Lafayette, IN 47907, USA.

Funding

Compromised Resolution of Inflammation following Nanoparticle Exposure in Metabolic SyndromeR01ES033173 · NIEHS · PURDUE UNIVERSITY · PI Jonathan Henry Shannahan · 2022 to 2026
$1.7M
NIEHS NIH HHS R01 ES033173
6 · The paper itself

Abstract

Omics analyses collectively refer to the possibility of profiling genetic variants, RNA, epigenetic markers, proteins, lipids, and metabolites. The most common analytical approaches used for detecting molecules present within biofluids related to metabolism are vibrational spectroscopy techniques, represented by infrared, Raman, and nuclear magnetic resonance (NMR) spectroscopies and mass spectrometry (MS). Omics-based assessments utilizing MS are rapidly expanding and being applied to various scientific disciplines and clinical settings. Most of the omics instruments are operated by specialists in dedicated laboratories; however, the development of miniature portable omics has made the technology more available to users for field applications. Variations in molecular information gained from omics approaches are useful for evaluating human health following environmental exposure and the development and progression of numerous diseases. As MS technology develops so do statistical and machine learning methods for the detection of molecular deviations from personalized metabolism, which are correlated to altered health conditions, and they are intended to provide a multi-disciplinary overview for researchers interested in adding multiomic analysis to their current efforts. This includes an introduction to mass spectrometry-based omics technologies, current state-of-the-art capabilities and their respective strengths and limitations for surveying molecular information. Furthermore, we describe how knowledge gained from these assessments can be applied to personalized medicine and diagnostic strategies.

Indexed as

Environmental ExposureMass SpectrometryMetabolomicsBiomarkersGenomicsHumansProteomicsBiomarkers

Identifiers

PMID38623720
PMCPMC11163948

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.